Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 161 - 180 of 203
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jul 2010, 4:16 pm
Merrell Dow Pharmaceuticals, Inc., 509 US 579 which, in federal courts, displaced the Frye general acceptance standard based upon the Federal Rules of Evidence. [read post]
6 May 2010, 4:12 pm by Bexis
Metabolife International, Inc., 401 F.3d 1233, 1247 (11th Cir. 2005); Goebel v. [read post]
5 Apr 2010, 1:01 pm by Jeralyn
Dow Merrell Pharmaceuticals, Inc., which prohibit the use of inaccurate, nonspecific tests and/or conclusory reports because they do not prove the presence of marijuana in a seized substance. [read post]
22 Mar 2010, 4:13 am by Sean Wajert
Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1320 (9th Cir.), cert denied, 516 U.S. 869 (1995); see also In re W.R. [read post]
31 Dec 2009, 2:34 am by Sean Wajert
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and its federal and state progeny. [read post]
13 May 2009, 6:00 am
Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311 (9th Cir.), cert. denied, 516 U.S. 869 (1995) "Daubert II" and plaintiff's counsel, of course, said that this case could hardly be more different. [read post]
18 Feb 2009, 12:01 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 589 (1993) Can the Daubert requirement be fulfilled during the trial? [read post]